Safety and efficacy of PTH(1-84) at 18 and 24 months in women with postmenopausal osteoporosis receiving hormone therapy: Results from the POWER study

被引：0
|
作者：
Fogelman, I
Christiansen, C
Spector, T
Fraser, W
Fordham, J
机构：
[1] Guys Kings & St Thomas Hosp, Sch Med, London, England
[2] Ctr Clin & Basic Res, Ballerup, Denmark
[3] St Thomas Hosp, London, England
[4] Royal Liverpool Univ Hosp, London, England
[5] James Cook Univ Hosp, London, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S21 / S22
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of 36 months treatment of postmenopausal osteoporotic women with PTH (1-84)
    Recker, R. R.
    Zanchetta, J. R.
    Mautalen, C. A.
    Man, Z.
    Leib, E. S.
    Morris, S. A.
    Greisen, H.
    Fox, J.
    [J]. BONE, 2009, 44 (02) : S431 - S431
  • [2] Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study
    Zanchetta, Jose R.
    Bogado, Cesar E.
    Cisari, Carlo
    Aslanidis, Spyros
    Greisen, Hanna
    Fox, John
    Lems, Willem
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (11) : 2627 - 2633
  • [3] Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis
    Black, D. M.
    Bilezikian, J. P.
    Greenspan, S. L.
    Wuester, C.
    Munoz-Torres, M.
    Bone, H. G.
    Rosen, C. J.
    Andersen, H. S.
    Hanley, D. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 (04) : 1503 - 1511
  • [4] PTH (1-84) prevents first vertebral fracture in postmenopausal women with osteoporosis: Results from the TOP study
    Ettinger, MP
    Greenspan, SL
    Marriott, TB
    Hanley, DA
    Zanchetta, JR
    Bone, HG
    Lindsay, R
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4103 - 4103
  • [5] PTH 1-84 EFFICACY: RESULTS AFTER 18 MONTH OF THERAPY
    Pastore, R.
    Borboni, P.
    Ventricini, A.
    Di Giacinto, P.
    Pavone, A.
    Frajese, G. V.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 347 - 347
  • [6] Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women
    Adami, Silvano
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3259 - 3274
  • [7] Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
    Pietrogrande, Luca
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2009, 1 : 193 - 203
  • [8] Safety of PTH(1-84) after 24 months therapy and a 12 months follow-up period
    Perez-Edo, L.
    Zanchetta, J. R.
    Mautalen, C. A.
    Bolognese, M. A.
    Greisen, H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S241 - S242
  • [9] The safety and efficacy of PTH in women receiving hormone therapy
    Fogelman, I
    Fordham, JN
    Fraser, J
    Spector, T
    Christiansen, C
    [J]. BONE, 2005, 36 : S446 - S447
  • [10] Serum calcium levels in postmenopausal women with osteoporosis after 1, 6 and 12 months of PTH(1-84) treatment - The latest results from the peak trial
    Diaz-Curiel, M.
    Hosking, D.
    Brandi, M.
    Hyldstrup, L. H.
    Felsenberg, D.
    [J]. BONE, 2009, 44 (02) : S435 - S436
12345